| Identification | Back Directory | [Name]
2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- | [CAS]
390800-88-1 | [Synonyms]
Bortezomib-d15
Bortezomib Trimer
(1R,2S)-Bortezomib
Bortezomib trimer API
Bortezomib ((1R,2S)-Bortezomib)
Bortezomib impurity 10/(1R,2S)-Bortezomib
Bortezomib Trimer ((1R,2S)-Bortezomib Trimer)
2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- | [EINECS(EC#)]
816-310-1 | [Molecular Formula]
C57H69B3N12O9 | [MDL Number]
MFCD32644677 | [MOL File]
390800-88-1.mol | [Molecular Weight]
1098.67 |
| Hazard Information | Back Directory | [Uses]
Bortezomib Trimer is derived from Bortezomib (B675700), which is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
| Company Name: |
Roark Standards
|
| Tel: |
0755-83552066 15986688328 |
| Website: |
roarkstandards.com |
|